Five-year survival in 432 cirrhotic patients with hepatocellular carcinoma (HCC) ≤4cm treated with us-guided percutaneous laser ablation (PLA): A multicentric study von Pacella, CM, Francica, G, Bizzarri, G, Arienti, V, Magnolfi, F, Di Lascio, FML, Caspani, B, Pretolani, S, Antico, E, Regine, R, Salomone Megna, A, Sponza, M

Volltext